Biotechnology in Japan

Introduction

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.

*The Japanese biotechnology market had total revenue of $36,238.4 million in 2010, representing a compound annual growth rate (CAGR) of 11.1% between 2006 and 2010.

*Medical/Healthcare sales proved the most lucrative for the Japanese biotechnology market in 2010, with total revenues of $15,365.1 million, equivalent to 42.4% of the market's overall value.

*The performance of the market is forecast to accelerate, with an anticipated CAGR of 11.6% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $62,657.6 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Japan economy

Key Questions Answered

What was the size of the Japan biotechnology market by value in 2010?

What will be the size of the Japan biotechnology market in 2015?

What factors are affecting the strength of competition in the Japan biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Japan's biotechnology market?
[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Substitutes 17
Rivalry 18
LEADING COMPANIES 19
Kyowa Hakko Kirin Co., Ltd. 19
Mitsubishi Tanabe Pharma Corporation 23
MARKET FORECASTS 26
Market value forecast 26
MACROECONOMIC INDICATORS 27
APPENDIX 29
Methodology 29
Industry associations 30
Related Datamonitor research 30
Disclaimer 31
ABOUT DATAMONITOR 32
Premium Reports 32
Summary Reports 32
Datamonitor consulting 32

LIST OF TABLES
Table 1: Japan biotechnology market value: $ million, 2006–10 10
Table 2: Japan biotechnology market segmentation I:% share, by value, 2010 11
Table 3: Japan biotechnology market segmentation II: % share, by value, 2010 12
Table 4: Kyowa Hakko Kirin Co., Ltd.: key facts 19
Table 5: Kyowa Hakko Kirin Co., Ltd.: key financials ($) 20
Table 6: Kyowa Hakko Kirin Co., Ltd.: key financials (¥) 20
Table 7: Kyowa Hakko Kirin Co., Ltd.: key financial ratios 21
Table 8: Mitsubishi Tanabe Pharma Corporation: key facts 23
Table 9: Mitsubishi Tanabe Pharma Corporation: key financials ($) 24
Table 10: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 24
Table 11: Mitsubishi Tanabe Pharma Corporation: key financial ratios 24
Table 12: Japan biotechnology market value forecast: $ million, 2010–15 26
Table 13: Japan size of population (million), 2006–10 27
Table 14: Japan gdp (constant 2000 prices, $ billion), 2006–10 27
Table 15: Japan gdp (current prices, $ billion), 2006–10 27
Table 16: Japan inflation, 2006–10 28
Table 17: Japan consumer price index (absolute), 2006–10 28
Table 18: Japan exchange rate, 2006–10 28

LIST OF FIGURES
Figure 1: Japan biotechnology market value: $ million, 2006–10 10
Figure 2: Japan biotechnology market segmentation I:% share, by value, 2010 11
Figure 3: Japan biotechnology market segmentation II: % share, by value, 2010 12
Figure 4: Forces driving competition in the biotechnology market in Japan, 2010 13
Figure 5: Drivers of buyer power in the biotechnology market in Japan, 2010 14
Figure 6: Drivers of supplier power in the biotechnology market in Japan, 2010 15
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Japan, 2010 16
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Japan, 2010 17
Figure 9: Drivers of degree of rivalry in the biotechnology market in Japan, 2010 18
Figure 10: Kyowa Hakko Kirin Co., Ltd.: revenues & profitability 21
Figure 11: Kyowa Hakko Kirin Co., Ltd.: assets & liabilities 22
Figure 12: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 25
Figure 13: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 25
Figure 14: Japan biotechnology market value forecast: $ million, 2010–15 26


[Inhaltsverzeichnis ausblenden]